positions available now

Tag Archives: TGA

Hand sanitiser – What do you need to know to supply in Australia?

The COVID-19 pandemic has seen the TGA rapidly changing the regulatory landscape for in-demand products that can help reduce the spread of the virus. Given all the changes taking place, it can be difficult to ascertain exactly how product categories … Continue reading

Posted in Commercialisation Services, Regulatory Services, TGA | Tagged , , , , , | Comments Off on Hand sanitiser – What do you need to know to supply in Australia?

Brexit – What’s the impact on medicines and medical devices supplied in Australia?

  The long-awaited Brexit is underway with the UK exiting the EU on 31 January 2020 A transition period is now in effect until the end of 2020 with the possibility for extension. Its status quo for Australia during the transition … Continue reading

Posted in Regulatory Services, TGA, Uncategorized | Tagged , , , , , | Comments Off on Brexit – What’s the impact on medicines and medical devices supplied in Australia?

TGO 91 and TGO 92 – are your labels ready?

Following the 4-year transition period, the medicine labelling Therapeutic Goods Orders (TGOs), TGO 91 for prescription medicines and TGO 92 for non-prescription medicines, will become mandatory on 1 September 2020. Medicines that are released for supply on or after 1 September … Continue reading

Posted in Life Sciences Industry, Regulatory Services, TGA | Tagged , , | Comments Off on TGO 91 and TGO 92 – are your labels ready?

No CE mark? No problem.

Changes to legislation have increased flexibility for Sponsors looking to market medical devices in Australia. Historically the TGA has only recognised EC certificates from European notified bodies or a TGA conformity assessment to support the inclusion of a Medical Device … Continue reading

Posted in E-Health/Technology, FDA, Regulatory Services, TGA | Tagged , , , , | Comments Off on No CE mark? No problem.

Making the most of complementary medicines reforms

In March this year the TGA finally started rolling out the long awaited Complementary Medicine Reforms.    One of the most significant changes for sponsors of listed complementary medicines is the abolition of the “free text” box for indications.  All … Continue reading

Posted in Regulatory Services, TGA | Tagged , , , | Comments Off on Making the most of complementary medicines reforms

What is Happening with the Provisional Approval Pathway?

We’ve come a long way When the independent review of medicines and medical devices regulation was announced in October 2014, the pharmaceutical sector immediately saw the opportunity for an expediated approval pathway for certain prescription medicines. A provisional approval pathway would allow … Continue reading

Posted in Life Sciences Industry, Regulatory Services, TGA | Tagged , , | Comments Off on What is Happening with the Provisional Approval Pathway?

New ‘SmPC’ Format for the Australian Product Information

The TGA have published a new form for providing the product information (PI) which means more work for regulatory teams but an enhancement of the quality use of medicines for Australian patients.  The new form will be implemented over a … Continue reading

Posted in Regulatory Services, TGA | Tagged , , , | Comments Off on New ‘SmPC’ Format for the Australian Product Information

Transition to eCTD is gaining momentum in Australia

At the 2017 ARCS Annual Conference, the TGA announced that applications considered under the priority review pathway will be required to be submitted in eCTD format. In making this important announcement, the TGA acknowledged the clear benefits of eCTD for … Continue reading

Posted in Commercial Eyes, E-Health/Technology, Regulatory Services, TGA | Tagged , , | Comments Off on Transition to eCTD is gaining momentum in Australia

TGA Inspections are Coming – Is your Company Ready?

The TGA has recently concluded its pilot program in Pharmacovigilance inspections in Australia.  Numerous companies volunteered to take part in this inspection program, and from those volunteers the TGA selected ten companies.  The selection process by the TGA considered a) … Continue reading

Posted in Medical Services, Pharmacovigilance, TGA | Tagged , , | Comments Off on TGA Inspections are Coming – Is your Company Ready?

Proposed updates to GVP Module VI and what this might mean for our clients

Good pharmacovigilance practices (GVP) are a set of measures drawn up to facilitate the performance of pharmacovigilance in the European Union (EU). GVP apply to marketing-authorisation holders, the European Medicines Agency and medicines regulatory authorities in EU Member States. The … Continue reading

Posted in Life Sciences Industry, Pharmacovigilance, TGA | Tagged , , , | Comments Off on Proposed updates to GVP Module VI and what this might mean for our clients
Copyright © 2014 Commercial Eyes